9 Honest Facts About Ashwagandha for Menopause Stress, Cortisol, and Sleep Before You Start Taking It
The number of women who've mentioned taking ashwagandha almost apologetically — like it's a guilty secret — is striking. There's something about the way it's sold that makes it feel both miraculous and slightly suspect at the same time. The truth lands somewhere in the middle, and for thyroid patients especially, this is one supplement that deserves a proper conversation with a doctor before it becomes a daily habit.
Learn more about Rose →It Is a Genuine Adaptogen With a Mechanism That Makes Physiological Sense
Ashwagandha (Withania somnifera) contains active compounds called withanolides that appear to modulate the hypothalamic-pituitary-adrenal (HPA) axis — the system that governs cortisol release. In perimenopause, declining oestrogen disrupts HPA axis regulation, which is part of why stress feels more overwhelming and cortisol patterns become erratic. This isn't folk medicine hand-waving; the proposed mechanism is grounded in real neuroendocrinology, even if the clinical evidence is still catching up.
Clinical Trials Show Modest but Real Reductions in Cortisol and Perceived Stress
Several small-to-medium randomised controlled trials — including a well-cited 2019 study published in Medicine — found that 240–600mg daily of ashwagandha root extract reduced serum cortisol levels and self-reported stress scores compared to placebo over 8–12 weeks. The effect sizes are real but modest: this is not a dramatic cortisol reset. Women with severely dysregulated HPA function due to perimenopause should view it as one supportive tool among several, not a standalone solution.
Sleep Improvements Are Among Its Most Consistently Reported Benefits
A 2021 randomised, double-blind, placebo-controlled trial in PLOS ONE found that ashwagandha root extract (600mg daily) significantly improved sleep quality, sleep onset latency, and morning alertness in adults with self-reported sleep problems. The mechanism likely involves its effect on the stress response and its interaction with GABA receptors rather than direct sedation. For perimenopausal women whose sleep disruption is primarily stress- and anxiety-driven rather than purely hot-flush-driven, this is where ashwagandha has its strongest practical case.
It Can Raise Thyroid Hormone Levels — Which Matters Enormously in This Population
Ashwagandha has been shown in multiple studies to increase levels of T3 and T4 thyroid hormones, likely by stimulating thyroid activity. For the general population this may sound neutral or even positive, but thyroid dysfunction — both hypothyroidism and subclinical thyroid irregularities — is significantly more common in perimenopausal and menopausal women. Anyone already taking levothyroxine or managing Hashimoto's thyroiditis should treat this interaction as a clinical concern, not a footnote, and discuss it with their prescribing doctor before starting.
Women With Autoimmune Conditions Should Exercise Real Caution
Ashwagandha is classified as an immune-stimulating herb, meaning it may upregulate immune system activity. For women with autoimmune conditions — including Hashimoto's thyroiditis, rheumatoid arthritis, lupus, or multiple sclerosis — this immune stimulation has the potential to aggravate the underlying condition. This isn't a theoretical concern invented by overly cautious practitioners; it reflects a well-understood principle of immunomodulatory herbs. The overlap between perimenopause and autoimmune disease flares is significant enough that this contraindication applies to a meaningful portion of women considering it.
The Evidence Specifically in Menopausal Women Is Thin
Most ashwagandha trials have been conducted in mixed-sex adult populations under general stress conditions, not in women specifically experiencing perimenopause or post-menopause. A small number of studies have examined it in women with sexual dysfunction and menopausal symptoms with promising results, but these trials are typically underpowered and short-term. The extrapolation from general stress populations to women with oestrogen-driven HPA disruption is reasonable but not yet well validated — honest marketing would acknowledge this gap.
It Does Not Replace or Replicate the Effect of Oestrogen
Ashwagandha is sometimes positioned — subtly or explicitly — as a hormone-balancing supplement, implying it addresses the root cause of menopausal symptoms. It does not contain phytoestrogens, does not raise endogenous oestrogen levels, and does not address the underlying hormonal shifts of menopause. What it may do is reduce the stress amplification of those symptoms, which is genuinely useful, but framing it as hormonal support overstates the evidence and risks women delaying conversations about evidence-based options like HRT.
Dosing, Formulation, and Quality Vary Wildly Between Products
The trials that produced positive results typically used standardised root extract at doses of 240–600mg daily with a defined withanolide concentration — usually around 5%. Many products on the market use whole root powder, different plant parts, or unstandardised extracts, making it genuinely difficult to know whether a given supplement delivers anything close to a studied dose. Supplement regulation in most countries does not require proof of efficacy or even consistency, so product quality is a legitimate variable that affects outcomes.
Side Effects Are Generally Mild but Not Absent — and Liver Cases Have Been Reported
Common side effects include digestive upset, loose stools, and drowsiness, especially at higher doses — manageable for most people but worth knowing. More seriously, a small number of case reports have linked ashwagandha use to drug-induced liver injury (DILI), including cases serious enough to require hospitalisation, though causality is difficult to establish definitively in case reports. Women with existing liver conditions, or those taking hepatically-metabolised medications, should factor this in and monitor for symptoms like jaundice, dark urine, or unexplained fatigue when starting use.
Want to go deeper?
Rose covers every symptom, supplement, and condition in full detail — evidence-graded and agenda-free.
Rose is a free, evidence-based reference built for women navigating perimenopause and menopause. No ads. No products to sell. No agenda. Just honest answers — because every woman in this season deserves a trusted friend who has done the research.